Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cigarette Smoking Increased Risk of Overall Mortality in Patients With Non-alcoholic Fatty Liver Disease: A Nationwide Population-Based Cohort Study
Phunchai Charatcharoenwitthaya, Khemajira Karaketklang, Wichai Aekplakorn
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Treatments for NAFLD: State of Art
Alessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2350-2350
Open Access | Times Cited: 161
Cigarette smoking and liver diseases
David Martí‐Aguado, Ana Clemente, Ramón Bataller
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 191-205
Open Access | Times Cited: 104
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors
Emir Muzurović, Carol Chiung‐Hui Peng, Matthew J. Belanger, et al.
Hypertension (2022) Vol. 79, Iss. 7, pp. 1319-1326
Closed Access | Times Cited: 85
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 1
Tobacco, Cigarettes, and the Liver: The Smoking Gun
Madhumita Premkumar, Anil C. Anand
Journal of Clinical and Experimental Hepatology (2021) Vol. 11, Iss. 6, pp. 700-712
Open Access | Times Cited: 44
Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective
Shelley E. Keating, Yogesh Chawla, Arka De, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 959-976
Open Access | Times Cited: 7
ASSOCIATION OF SMOKING AND SEVERITY OF COVID-19 INFECTION AMONG 5,889 PATIENTS IN MALAYSIA: A MULTI-CENTER OBSERVATIONAL STUDY
Norliana Ismail, Noraryana Hassan, Muhammad Hairul Nizam Abd Hamid, et al.
International Journal of Infectious Diseases (2022) Vol. 116, pp. 189-196
Open Access | Times Cited: 22
Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018
Zheng Yang, Daoqing Gong, Xinxiang He, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 13
Relevant Aspects of Combined Protocols for Prevention of N(M)AFLD and Other Non‐Communicable Diseases
Luis A. Videla, Rodrigo Valenzuela, Jessica Zúñiga‐Hernández, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 7
Closed Access | Times Cited: 5
A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease
Dana Ivancovsky‐Wajcman, Christopher J. Byrne, John Dillon, et al.
Hepatology (2024)
Open Access | Times Cited: 5
A comprehensive analysis of the impact of smoking on adverse clinical outcomes of steatotic liver diseases
Keungmo Yang, Jae Jun Lee, Ji Won Han, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
HNRNPA2B1, as a m6A Reader, Promotes Tumorigenesis and Metastasis of Oral Squamous Cell Carcinoma
Feiya Zhu, Tianru Yang, Mianfeng Yao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29
Dose optimization of non-selective beta blockers among esophageal varices patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a hospital-based cross-sectional study
Getaneh Alemu, Segenet Bizuneh Mengistu, Yonas Gedamu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Prevalence of anemia and association with mortality in community-dwelling elderly in Thailand
Ekapun Karoopongse, Varalak Srinonprasert, Chalobol Chalermsri, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Association between smoking and non-alcoholic fatty liver disease in Southeast Asia
Hassan Mumtaz, Madiha Hameed, Abdul Basit Sangah, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 16
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD
Oluwafemi Balogun, Jeffrey Wang, Emad Salman Shaikh, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 7
Association of healthy lifestyles with risk of all-cause and cause-specific mortality among individuals with metabolic dysfunction-associated steatotic liver disease: results from the DFTJ cohort
Qilin Deng, Yingchen Zhang, Xin Guan, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 2
Meta-analysis of the association between major foods with added fructose and non-alcoholic fatty liver disease
Wenqi Liu, Daokuan Zhai, Tingjing Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 12, pp. 5551-5561
Closed Access | Times Cited: 6
Metabolic and Risk Profiles of Lean and Non-Lean Hepatic Steatosis among US Adults
Meiling Li, Weiping Zhang, Xiude Li, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2856-2856
Open Access | Times Cited: 6
Impacts of smoking on alcoholic liver disease: a nationwide cohort study
Jeong‐Ju Yoo, Dong Hyeon Lee, Sang Gyune Kim, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Structural changes of proteins in liver cirrhosis and consequential changes in their function
Nikola Gligorijević, Simeon Minić, Olgica Nedić
World Journal of Gastroenterology (2022) Vol. 28, Iss. 29, pp. 3780-3792
Open Access | Times Cited: 7
Possible correlation between high circulatory levels of trimethylamine-N-oxide and 2177G>C polymorphisms of hepatic flavin containing monooxygenase 3 in Kurdish Population with non-alcoholic fatty liver disease
Mohammad Moradzad, Mohammad Abdi, Farshad Sheikh Esmaeili, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 7, pp. 5927-5937
Closed Access | Times Cited: 6
Associations between Healthy Lifestyle and All-Cause Mortality in Individuals with Metabolic Associated Fatty Liver Disease
Xinyu Wang, Aruna Wang, Ruosu Zhang, et al.
Nutrients (2022) Vol. 14, Iss. 20, pp. 4222-4222
Open Access | Times Cited: 6
The gut microbiome and nicotine metabolism in NAFLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Science Bulletin (2023) Vol. 68, Iss. 3, pp. 233-235
Open Access | Times Cited: 3
Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats
Pablo Alvarez Auth, Gustavo Ratti da Silva, Eduarda Carolina Amaral, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top